REG - Animalcare Group PLC - Exercise of Options and Total Voting Rights

AnimalcareAnnouncement

19/11/2025 07:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251119:nRSS1495Ia&default-theme=true

RNS Number : 1495I  Animalcare Group PLC  19 November 2025

 

ANIMALCARE GROUP PLC

 

 ("Animalcare", the "Company" or the "Group")

 

Exercise of Options and Total Voting Rights

 

19 November 2025. Animalcare Group plc (AIM: ANCR), the international animal
health business, announces that, following an exercise of options awarded at
nil cost under the Company's Long Term Incentive Plan over 56,873 new ordinary
shares of 20p each in the Company ("New Ordinary Shares"), application has
been made to the London Stock Exchange for the admission of 56,873 New
Ordinary Shares to trading on AIM. It is expected that admission of the New
Ordinary Shares will become effective, and dealings will commence in the New
Ordinary Shares at 08.00 am on 24 November 2025.

 

The New Ordinary Shares, when issued, will be fully paid and will
rank pari-passu in all respects with the existing ordinary shares, including
the right to receive all dividends and other distributions declared, made or
paid after the date of issue. The issue and allotment of the New Ordinary
Shares will be within the Company's existing authorities.

 

Total Voting Rights

 

Subsequent to admission, there will be 69,045,945 ordinary shares of 20p each
in issue with voting rights. No shares are held in treasury. This figure may
be used by shareholders as the denominator for the calculations by which they
will determine if they are required to notify their interest in, or a change
to their interest in, the share capital of the Company under the FCA's
Disclosure and Transparency Rules.

 

 Animalcare Group Plc
 Jennifer Winter, Chief Executive Officer                                                                                              +44 (0)1904 487 687

 Chris Brewster, Chief Financial Officer

 Media/ investor relations                                                                                                             communications@animalcaregroup.com (mailto:communications@animalcaregroup.com)

 Stifel Nicolaus Europe Limited                                                                                                        +44 (0)20 7710 7600

 (Nominated Adviser & Joint Broker)
 Ben Maddison

 Francis North

 Jason Grossman

 Panmure Liberum                                                                                                                       +44 (0)20 7886 2500

 (Joint Broker)
 Corporate Finance

 Freddy Crossley/Emma Earl

 Corporate Banking

 Rupert Dearden

 Alma Strategic                                                                                                                        +44 (0)20 3405 0205
 Communications

                                                                                                                                       animalcare@almastrategic.com (mailto:animalcare@almastrategic.com)

 Caroline
 Forde

 Kinvara Verdon

 Rose Docherty

 

About Animalcare

 

Animalcare Group plc is a UK AIM-listed international veterinary sales and
marketing organisation. Animalcare operates in seven European countries as
well as Australia, New Zealand and the UAE and exports to approximately 40
countries in Europe and worldwide. The Group is focused on bringing new and
innovative products to market through its own development pipeline,
partnerships and via acquisition.

 

For more information about Animalcare, please visit www.animalcaregroup.com
(http://www.animalcaregroup.com/)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TVRFFESWUEISELF



            Copyright 2019 Regulatory News Service, all rights reserved